Patient Resources

There is a patient support brochure available for patients who have been prescribed XELJANZ for the treatment of:

  • Rheumatoid Arthritis (RA)
  • Psoriatic Arthritis (PsA)
  • Ulcerative Colitis (UC)

Printed versions of these brochures are available to order and contain information on:

  • How XELJANZ works
  • Dosing and administration
  • Key safety information on considerations before, during and after treatment

Click the "Order item here" to begin your request

RA Patient Brochure
This brochure should only be given to patients who have been prescribed XELJANZ for RA.

 

PsA Patient Brochure
This brochure should only be given to patients who have been prescribed XELJANZ for PsA.

 

UC Patient Brochure
This brochure should only be given to patients who have been prescribed XELJANZ for UC.

 

XELJANZ Risk Minimisation Programme (RMP) materials, including a Patient Alert Card, Prescriber Checklists and a Prescriber Brochure are available from https://www.medicines.org.uk/emc/. Patients treated with XELJANZ should be given the Patient Alert Card. Printed versions of the RMP materials can be ordered at Medisa.

 

 

PP-XEL-GBR-2404. August 2020